Related references
Note: Only part of the references are listed.Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma
Elizabeth C. Randall et al.
CANCER RESEARCH (2020)
Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents
Oguzhan Doganlar et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2020)
AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion
Anne Schuster et al.
NATURE COMMUNICATIONS (2020)
Apoptosis related microRNAs and MGMT in glioblastoma cell lines submitted to treatments with ionizing radiation and temozolomide
Felipe Amstalden Trevisan et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2020)
The reversal of MRP1 expression induced by low-frequency and low-intensity ultrasound and curcumin mediated by VEGF in brain glioma
Lei Yao et al.
ONCOTARGETS AND THERAPY (2019)
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
Guo-Zhong Yi et al.
BRAIN (2019)
Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors
Edouard Alphandery et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
Da Wang et al.
DRUG DELIVERY (2019)
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Xin Zhang et al.
CELL DEATH & DISEASE (2018)
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
Mark C. de Gooijer et al.
NEOPLASIA (2018)
IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway
Kaishu Li et al.
ONCOTARGET (2017)
Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment
Tonny Lagerweij et al.
ANGIOGENESIS (2017)
Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway
Anika M. S. Hartz et al.
JOURNAL OF NEUROSCIENCE (2016)
Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line
Guo-zhong Yi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Changes in mesenchymal stem cells following long-term culture in vitro
Yajun Gu et al.
MOLECULAR MEDICINE REPORTS (2016)
Origin of the U87MG glioma cell line: Good news and bad news
Marie Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Management of glioblastoma after recurrence: A changing paradigm
Supriya Mallick et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2016)
Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
Hayley P. Ellis et al.
FRONTIERS IN ONCOLOGY (2015)
被撤回的出版物: Recurrent Glioblastoma: Where we stand(Retracted article. See vol. 6, pg. 153, 2017)
Sanjoy Roy et al.
SOUTH ASIAN JOURNAL OF CANCER (2015)
Karyotypically distinct U251, U373, and SNB19 glioma cell lines are of the same origin but have different drug treatment sensitivities
Alexey A. Stepanenko et al.
GENE (2014)
Reactive Oxygen Species Responsive Nanoprodrug to Treat Intracranial Glioblastoma
Bong-Seop Lee et al.
ACS NANO (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
ROS implication in a new antitumor strategy based on non-thermal plasma
Marc Vandamme et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells
Yajie Liang et al.
JOURNAL OF BIOMEDICAL OPTICS (2012)
A Method to Rapidly and Accurately Compare the Relative Efficacies of Non-invasive Imaging Reporter Genes in a Mouse Model and its Application to Luciferase Reporters
Jose S. Gil et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma
William T. Phillips et al.
NEURO-ONCOLOGY (2012)
An Extensive Invasive Intracranial Human Glioblastoma Xenograft Model Role of High Level Matrix Metalloproteinase 9
Yunge Zhao et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice
Sudhir H. Ranganath et al.
BIOMATERIALS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
Brian Thiessen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity
Anika M. S. Hartz et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Estrogen Receptor β Signaling through Phosphatase and Tensin Homolog/Phosphoinositide 3-Kinase/Akt/Glycogen Synthase Kinase 3 Down-Regulates Blood-Brain Barrier Breast Cancer Resistance Protein
A. M. S. Hartz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
High-grade glioma mouse models and their applicability for preclinical testing
Nienke A. de Vries et al.
CANCER TREATMENT REVIEWS (2009)
An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)
Joseph W. Polli et al.
DRUG METABOLISM AND DISPOSITION (2009)
Relative sensitivities of U87 glioblastoma (GBM) xenografts expressing mutant epidermal growth factor receptor (EGFRvIII) or wild type EGFR to combined therapy with cetuximab and/or temozolomide (TMZ) and radiation therapy (RT)
P. R. Wachsberge et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort:: Neuritic plaques and neurofibrillary tangles Do Count when staging disease severity
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression
Marianela Candolfi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Luciferase from the Italian firefly Luciola italica:: Molecular cloning and expression
Bruce R. Branchini et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2006)
Mouse models of brain tumors and their applications in preclinical trials
Elena I. Fomchenko et al.
CLINICAL CANCER RESEARCH (2006)
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma
D Koul et al.
MOLECULAR CANCER THERAPEUTICS (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
